Ibaraki, Japan

Akira Suga


Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akira Suga: Pioneering Innovator Shaping the Future of Pharmaceuticals

Introduction:

Akira Suga, a trailblazing inventor based in Ibaraki, Japan, has made significant contributions to the world of patents and inventions with her relentless pursuit of innovation and unwavering commitment to excellence.

Latest Patents:

Akira Suga's latest patents include groundbreaking inventions such as Pyrazolotriazole derivatives, Hydroxamic acid derivative, and a compound with matrix metalloprotease inhibitory activity. These patents showcase her expertise in pharmaceutical compositions and the production processes essential for preventing and treating diseases related to connective tissue breakage.

Career Highlights:

Throughout her illustrious career, Akira Suga has secured a total of three patents, positioning her as a leading figure in the field of pharmaceutical innovations. Her dedication to pushing boundaries and thinking boldly has set her apart as a visionary inventor with a passion for driving positive change in the healthcare industry.

Collaborations:

In her work at the esteemed Yamanouchi Pharmaceutical Company Ltd., Akira Suga has collaborated with notable coworkers such as Yasuo Isomura and Seijiro Akamatsu. Together, they have collectively contributed to expanding the frontiers of pharmaceutical research and development, paving the way for cutting-edge solutions in healthcare.

Conclusion:

Akira Suga's remarkable journey as an inventor underscores her lasting impact on the world of patents and inventions. Her innovative spirit, coupled with her commitment to excellence, continues to inspire future generations of inventors to dream big and create transformative solutions for the betterment of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…